152 related articles for article (PubMed ID: 10563333)
1. Sphingolipid hydrolyzing enzymes in the gastrointestinal tract.
Duan RD; Nilsson A
Methods Enzymol; 2000; 311():276-86. PubMed ID: 10563333
[No Abstract] [Full Text] [Related]
2. Alkaline sphingomyelinases and ceramidases of the gastrointestinal tract.
Nilsson A; Duan RD
Chem Phys Lipids; 1999 Nov; 102(1-2):97-105. PubMed ID: 11001564
[TBL] [Abstract][Full Text] [Related]
3. The therapeutic potential of modulating the ceramide/sphingomyelin pathway.
Kolesnick R
J Clin Invest; 2002 Jul; 110(1):3-8. PubMed ID: 12093880
[No Abstract] [Full Text] [Related]
4. Measurement of ceramide and sphingolipid metabolism in tumors: potential modulation of chemotherapy.
Modrak DE
Methods Mol Med; 2005; 111():183-94. PubMed ID: 15911980
[TBL] [Abstract][Full Text] [Related]
5. Analysis of sphingomyelin and ceramide levels and the enzymes regulating their metabolism in response to cell stress.
Dobrowsky RT; Kolesnick RN
Methods Cell Biol; 2001; 66():135-65. PubMed ID: 11396001
[No Abstract] [Full Text] [Related]
6. Sphingolipid metabolism in the regulation of bioactive molecules.
Luberto C; Hannun YA
Lipids; 1999; 34 Suppl():S5-11. PubMed ID: 10419081
[No Abstract] [Full Text] [Related]
7. Sphingomyelin metabolism is developmentally regulated in rat lung.
Longo CA; Tyler D; Mallampalli RK
Am J Respir Cell Mol Biol; 1997 May; 16(5):605-12. PubMed ID: 9160843
[TBL] [Abstract][Full Text] [Related]
8. Digestion of ceramide by human milk bile salt-stimulated lipase.
Nyberg L; Farooqi A; Bläckberg L; Duan RD; Nilsson A; Hernell O
J Pediatr Gastroenterol Nutr; 1998 Nov; 27(5):560-7. PubMed ID: 9822324
[TBL] [Abstract][Full Text] [Related]
9. Probing compartment-specific sphingolipids with targeted bacterial sphingomyelinases and ceramidases.
Sakamoto W; Canals D; Salamone S; Allopenna J; Clarke CJ; Snider J; Obeid LM; Hannun YA
J Lipid Res; 2019 Nov; 60(11):1841-1850. PubMed ID: 31243119
[TBL] [Abstract][Full Text] [Related]
10. Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk.
Samad F; Hester KD; Yang G; Hannun YA; Bielawski J
Diabetes; 2006 Sep; 55(9):2579-87. PubMed ID: 16936207
[TBL] [Abstract][Full Text] [Related]
11. PPARalpha agonist induces the accumulation of ceramide in the heart of rats fed high-fat diet.
Baranowski M; Błachnio A; Zabielski P; Górski J
J Physiol Pharmacol; 2007 Mar; 58(1):57-72. PubMed ID: 17440226
[TBL] [Abstract][Full Text] [Related]
12. Pioglitazone induces de novo ceramide synthesis in the rat heart.
Baranowski M; Blachnio A; Zabielski P; Gorski J
Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):99-111. PubMed ID: 17259076
[TBL] [Abstract][Full Text] [Related]
13. Potential therapeutic targets for atherosclerosis in sphingolipid metabolism.
Yu Z; Peng Q; Huang Y
Clin Sci (Lond); 2019 Mar; 133(6):763-776. PubMed ID: 30890654
[TBL] [Abstract][Full Text] [Related]
14. The effect of high-fat diet on the sphingolipid pathway of signal transduction in regenerating rat liver.
Zabielski P; Baranowski M; Błachnio-Zabielska A; Zendzian-Piotrowska M; Górski J
Prostaglandins Other Lipid Mediat; 2010 Nov; 93(3-4):75-83. PubMed ID: 20599517
[TBL] [Abstract][Full Text] [Related]
15. Partial hepatectomy activates production of the pro-mitotic intermediates of the sphingomyelin signal transduction pathway in the rat liver.
Zabielski P; Baranowski M; Zendzian-Piotrowska M; Blachnio A; Gorski J
Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):277-84. PubMed ID: 17499747
[TBL] [Abstract][Full Text] [Related]
16. High fat diet induces ceramide and sphingomyelin formation in rat's liver nuclei.
Chocian G; Chabowski A; Zendzian-Piotrowska M; Harasim E; Łukaszuk B; Górski J
Mol Cell Biochem; 2010 Jul; 340(1-2):125-31. PubMed ID: 20174962
[TBL] [Abstract][Full Text] [Related]
17. Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space.
Tani M; Ito M; Igarashi Y
Cell Signal; 2007 Feb; 19(2):229-37. PubMed ID: 16963225
[TBL] [Abstract][Full Text] [Related]
18. Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases.
Canals D; Perry DM; Jenkins RW; Hannun YA
Br J Pharmacol; 2011 Jun; 163(4):694-712. PubMed ID: 21615386
[TBL] [Abstract][Full Text] [Related]
19. Medicinal chemistry aspects of drug targets in sphingolipid metabolism.
Nussbaumer P
ChemMedChem; 2008 Apr; 3(4):543-51. PubMed ID: 18061920
[No Abstract] [Full Text] [Related]
20. Ceramide-mediated apoptosis of hepatocytes in vivo: a matter of the nucleus?
Hoekstra D
J Hepatol; 1999 Jul; 31(1):161-4. PubMed ID: 10424298
[No Abstract] [Full Text] [Related]
[Next] [New Search]
